Upcoming Economic Outlook - Report Highlights GlaxoSmithKline plc (ADR) and Bristol Myers Squibb Co.

Upcoming Economic Outlook - Report Highlights GlaxoSmithKline plc (ADR) and Bristol Myers Squibb Co.

ID: 152219

(firmenpresse) - HONG KONG -- (Marketwire) -- 06/01/12 -- Today, announced new reports highlighting GlaxoSmithKline plc (ADR) (NYSE: GSK) and Bristol Myers Squibb Co. (NYSE: BMY). Gain market insight with full analysis and research downloads available at .

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on GlaxoSmithKline plc (ADR) for its current position within the healthcare industry. GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The full research report on GlaxoSmithKline plc (ADR) (NYSE: GSK) is available here: .

Brighton Markets has released research on Bristol Myers Squibb Co. for its changing role within the healthcare industry. Bristol-Myers Squibb Company (BMS) is a global biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Its products are sold worldwide to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The full research report on Bristol Myers Squibb Co. (NYSE: BMY) is available here: .





About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.



Contact:

Jean Barnes


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Upcoming Economic Outlook - Report Highlights Thermo Fisher Scientific Inc. and MGM Resorts International A Forward Look, The Year Ahead - Featured Research on Halliburton Company and Pioneer Natural Resources
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 01.06.2012 - 13:00 Uhr
Sprache: Deutsch
News-ID 152219
Anzahl Zeichen: 0

contact information:
Town:

HONG KONG



Kategorie:

Commercial & Investment Banking



Diese Pressemitteilung wurde bisher 193 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Upcoming Economic Outlook - Report Highlights GlaxoSmithKline plc (ADR) and Bristol Myers Squibb Co."
steht unter der journalistisch-redaktionellen Verantwortung von

Brighton Markets (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Brighton Markets



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z